Percutaneous controlled thermocoagulation in the treatment of trigeminal neuralgia.
This study reviews the results and complications of 162 percutaneous thermocoagulations of the gasserian ganglion in 124 patients with typical idiopathic trigeminal neuralgia. The mean duration of follow-up observation was 3.7 years (range, 1-6 years). One hundred eighteen of 124 patients continued to show complete pain relief 1 month after the operation, and at the end of follow-up observation, 83 of 124 patients (67%) continued to enjoy complete pain relief (recurrence rate, 28.2%). Anesthesia dolorosa occurred in 3% of cases, dysesthesia in 3%, and paresthesia in 17%; neuroparalytic keratitis with permanent reduction of visual acuity was observed in 2% of cases, permanent diplopia in 1%, permanent hearing deficit in 3%, and permanent impairment of mastication in 3%. We compare thermocoagulation with other surgical procedures (microvascular decompression, glycerol injection, and percutaneous decompression) used in the treatment of trigeminal neuralgia.
Ischia
S
S
Institute of Anesthesiology and Intensive Care, University of Verona, School of Medicine, Ospedale Policlinico, Italy.
Luzzani
A
A
Polati
E
E
Ischia
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003714:Denervation; D004564:Electrocoagulation / Q000009:adverse effects; D005260:Female; D005990:Glycerol; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000601:surgery; D008875:Middle Aged; D012008:Recurrence; D014277:Trigeminal Neuralgia / Q000628:therapy*
D005990:Glycerol